Revelation Biosciences (NASDAQ:REVB) Issues Quarterly Earnings Results
Revelation Biosciences (NASDAQ:REVB – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($1.65) EPS for the quarter, missing the consensus estimate of ($1.41) by ($0.24), FiscalAI reports. Revelation Biosciences Price Performance Shares of Revelation Biosciences stock traded down $0.01 during trading on Friday, hitting $1.32. 65,539 shares of the stock [...]